Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

WCLC 2022 | Next steps for SANOVO trial for EGFRm+/MET+ NSCLC

Qing Zhou • 8 Aug 2022
WCLC 2022
Lung Cancer Non-Small Cell Lung Cancer
SANOVO

More from Qing Zhou

1:26
The challenge of treatment resistance in patients with advanced EGFR-mutated NSCLC
Qing Zhou • 8 Aug 2022
3:30
Comparing progression-free survival in the ASTRIS and SANOVO trials
Qing Zhou • 8 Aug 2022
4:39
Background of SANOVO trial for patients with advanced NSCLC
Qing Zhou • 8 Aug 2022
2:02
CROWN update: results of an asian subgroup analysis
Qing Zhou • 31 Aug 2021

Related Videos

1:03
The benefits of liquid biopsies for lung cancer in the community setting
Deepti Behl • 9 Apr 2024
0:57
STK-012-101: STK-012 in advanced solid tumors
Alexander Spira • 15 Mar 2024
3:34
FLAURA2: EGFRm dynamics in NSCLC treated with osimertinib
Pasi Jänne • 8 Apr 2024
0:54
FURVENT: furmonertinib in EGFR exon 20 mutant NSCLC
Alexander Spira • 15 Mar 2024
The content of VJOncology is intended for healthcare professionals